Categories: Technology

TREATMENT.COM AI INC. EXTENDS TERM OF MARKETING SERVICES PROVIDED BY I2I MARKETING GROUP

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

 | Source: Treatment.com AI Inc.

Vancouver, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) announces that, further to its news release dated January 24, 2025, it has extended the term of marketing and investor awareness services provided by i2i Marketing Group, LLC (i2i”) for an additional two (2) months, now expiring on September 23, 2025, in consideration of an additional USD$200,000.

i2i shall utilize digital marketing and online advertisements through such sites as Google and Bing. i2i does not currently own any interest, directly or indirectly, in the Company or its securities. i2i’s address is 1107 Key Plaza #222, Key West, Florida, USA, 33040 (phone: (312) 725-3843, email: contact@i2illc.com). i2i and its directors and officers are arm’s length from the Company.

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). With more than ~10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and enables greater consistency in quality of patient support. Treatment’s GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment’s products and services: www.treatment.com or email: info@treatment.com

FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO

ehamza@treatment.com

For media inquiries, contact: media@treatment.com

Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955

Cautionary Statement

This news release contains forward-looking statements relating to the future operations of Treatment and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, are forward- looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment’s expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

GlobeNews Wire

Recent Posts

How to Invest in Ethereum. Earn Cryptocurrency with the Best Cloud Mining in 2025

As a leading cloud mining platform, ICOminer offers stable daily returns with a principal refund…

1 hour ago

BitMart 7th Anniversary: Building the Gateway to Web3.0 and Pioneering a Free and Sustainable Crypto Financial Ecosystem

Mahe, Seychelles , March 15, 2025 (GLOBE NEWSWIRE) -- BitMart, a leading global digital asset…

1 hour ago

XRP Investors Rush to Participate in BlocScales $BLOC Seed Sale, as 20% of Allocation Sells Out in Record Time!

LIJA, Malta, March 15, 2025 (GLOBE NEWSWIRE) -- The XRP ecosystem is witnessing an unprecedented…

1 hour ago

Introducing Walletry.ai The Future of Crypto Wallets

Dubai, UAE, March 15, 2025 (GLOBE NEWSWIRE) -- The cryptocurrency industry is evolving at an…

1 hour ago

XRP Whales Rush to ExoraPad Presale as Ripple vs SEC Verdict NearsOver 40% Softcap Filled in Hours!

CORK, Ireland, March 15, 2025 (GLOBE NEWSWIRE) -- As Ripple’s long-standing legal battle with the…

1 hour ago

BingX Joins NBX 2025 as a Gold Sponsor: Empowering Blockchain Innovation

PANAMA CITY, March 15, 2025 /PRNewswire/ -- BingX, a global leading cryptocurrency exchange, is excited…

2 hours ago